CogState (CGS.AX) Stock Price
CogState Price
Over the last 19 years CogState grew revenue by 20.0% annually, reaching 53.09 M USD. Earnings per share have grown at 8.5% per year over the last 16 years. For CogState, the net margin of 19.1% is up versus 16.0% a few years ago. At today's price the dividend yield works out to roughly 1.29%. The payout ratio is around 35% of earnings. The consensus 12-month price target for CogState is 2.21 USD, about 0.2% below where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 84% above its 52-week low.
CogState stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of CogState over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how CogState stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing CogState's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | CogState Price |
|---|---|
| 8/31/2026 | 2.22 USD |
| 8/28/2026 | 2.24 USD |
| 8/27/2026 | 2.29 USD |
| 8/26/2026 | 2.21 USD |
| 8/25/2026 | 2.17 USD |
| 8/24/2026 | 2.18 USD |
| 8/21/2026 | 2.22 USD |
| 8/20/2026 | 2.20 USD |
| 8/19/2026 | 2.10 USD |
| 8/18/2026 | 1.95 USD |
| 8/17/2026 | 2.00 USD |
| 8/14/2026 | 2.00 USD |
| 8/13/2026 | 1.96 USD |
| 8/12/2026 | 1.97 USD |
| 8/11/2026 | 1.93 USD |
| 8/10/2026 | 1.91 USD |
| 8/7/2026 | 1.85 USD |
| 8/6/2026 | 1.88 USD |
| 8/5/2026 | 1.86 USD |
| 8/4/2026 | 1.79 USD |
| 8/3/2026 | 1.80 USD |
| 7/31/2026 | 1.79 USD |
| 7/30/2026 | 1.80 USD |
| 7/29/2026 | 1.86 USD |
| 7/28/2026 | 1.76 USD |
| 7/27/2026 | 1.77 USD |
| 7/24/2026 | 1.81 USD |
| 7/23/2026 | 1.85 USD |
| 7/22/2026 | 1.88 USD |
| 7/21/2026 | 1.94 USD |
CogState Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
CogState Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.00 | 18.00 | 26.00 | 28.00 | 21.00 | 22.00 | 32.00 | 45.00 | 40.00 | 43.00 | 53.00 | 128.00 | 106.00 | 121.00 | 138.00 | 146.00 |
| -9.09 | 80.00 | 44.44 | 7.69 | -25.00 | 4.76 | 45.45 | 40.63 | -11.11 | 7.50 | 23.26 | 141.51 | -17.19 | 14.15 | 14.05 | 5.80 |
| 50.00 | 55.56 | 50.00 | 53.57 | 42.86 | 40.91 | 53.13 | 57.78 | 50.00 | 55.81 | 60.38 | 60.38 | 60.38 | 60.38 | 60.38 | 60.38 |
| 5.00 | 10.00 | 13.00 | 15.00 | 9.00 | 9.00 | 17.00 | 26.00 | 20.00 | 24.00 | 32.00 | 77.28 | 64.00 | 73.06 | 83.32 | 88.15 |
| -2.00 | – | – | – | -3.00 | -2.00 | 6.00 | 10.00 | 3.00 | 7.00 | 13.00 | 23.00 | 19.00 | 22.00 | 25.00 | 26.00 |
| -20.00 | – | – | – | -14.29 | -9.09 | 18.75 | 22.22 | 7.50 | 16.28 | 24.53 | 17.97 | 17.92 | 18.18 | 18.12 | 17.81 |
| -3.00 | 1.00 | – | – | -2.00 | -1.00 | 5.00 | 7.00 | 3.00 | 5.00 | 10.00 | 16.00 | 21.00 | 26.00 | 32.00 | 25.00 |
| – | -133.33 | – | – | – | -50.00 | -600.00 | 40.00 | -57.14 | 66.67 | 100.00 | 60.00 | 31.25 | 23.81 | 23.08 | -21.88 |
| – | – | – | – | – | – | – | – | – | – | 0.03 | 0.03 | 0.03 | 0.03 | – | – |
| 100.17 | 117.45 | 113.85 | 115.20 | 119.20 | 159.36 | 173.06 | 176.82 | 176.34 | 173.10 | 174.01 | 174.01 | 174.01 | 174.01 | 174.01 | 174.01 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales CogState generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue CogState retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare CogState's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares CogState has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against CogState's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
CogState stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
CogState Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
CogState business model & stock analysis
CogState SWOT Analysis
Strengths
- Strong reputation in the cognitive assessment industry.
- Leading provider of computerized cognitive tests and clinical trial services.
- Extensive experience and expertise in developing and commercializing innovative cognitive assessment solutions.
- Robust intellectual property portfolio, providing a competitive advantage.
Weaknesses
- Dependency on a relatively small number of key clients for a significant portion of revenue.
- Limited market presence outside of North America and Europe.
- Relatively high research and development costs, impacting profitability.
Opportunities
- Increasing demand for cognitive assessment tools in healthcare, research, and pharmaceutical industries.
- Potential for expansion into emerging markets, such as Asia-Pacific and Latin America.
- Growing awareness and importance of early detection and intervention for cognitive disorders, creating a larger addressable market.
Threats
- Intense competition from other cognitive assessment providers.
- Regulatory challenges and compliance requirements in different countries.
- Economic downturn or budget constraints impacting customer spending on cognitive assessment solutions.
CogState Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
CogState historical P/E ratio, EBIT multiple, and P/S ratio
CogState annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
CogState shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
CogState Dividend History
1 years of dividend payments
CogState dividend history and estimates
Max
Details
CogState dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current CogState forecasts and price targets in September 2026
Analyst Price Targets 2026CogState Earnings Calls
CogState shareholder structure
| % | Name |
|---|---|
4.88485% | |
3.67792% | |
1.86216% | |
0.42719% | |
0.22367% | |
0.21870% |
CogState Beneficial Ownership Filings (SEC 13D/G)
CogState Executives and Management Board
12 members · avg. age 57 · 42 % women
Mr. Brad O'Connor
Chief Executive Officer, Managing Director, Executive Director · since 2004
1.10 M USD
Management
Mr. Darren Watson
Chief Financial Officer
Mr. Chris Edgar
Chief Scientific Officer
Ms. Rachel Colite
Executive Vice President - Clinical Trials
Ms. Kristi Geddes
General Counsel, Joint Company Secretary
Dr. Kaycee Sink
Chief Medical Officer
Mr. David Franks
Company Secretary
Board of Directors
Mr. Martyn Myer
Non-Executive Chairman of the Board
Ms. Ingrid Player
Independent Non-Executive Director
Ms. Kim Wenn
Independent Non-Executive Director
Dr. Richard Mohs
Independent Non-Executive Director
Mr. Richard van Den Broek (57)
Independent Non-Executive Director
Frequently asked questions about CogState
CogState Ltd is a leading provider of cognitive testing services for clinical trials, academic research, and healthcare. The company's business model revolves around using their digital tools and technologies to measure and enhance cognitive function in patients. By collaborating with pharmaceutical companies, academic institutions, and healthcare organizations, CogState Ltd aims to improve patient outcomes and accelerate the development of new treatments. With their expertise and extensive database, CogState Ltd offers customized solutions and prognostic insights to address the cognitive challenges faced in various industries.
CogState Ltd is primarily active in the healthcare and pharmaceutical industries.
The main competitors of CogState Ltd in the market are Cambridge Cognition Holdings PLC, Neurotrack Technologies Inc., and CogniFit Ltd. These companies also specialize in cognitive assessment and provide similar solutions and services. However, CogState Ltd distinguishes itself through its innovative technologies and partnerships, including collaborations with leading pharmaceutical companies. With its strong focus on enhancing the understanding and measurement of cognitive function, CogState Ltd continues to remain competitive in the market and deliver valuable solutions to its clients.
CogState Ltd is a renowned company with a rich history and background. Founded in 1999, CogState specializes in cognitive testing and offers innovative solutions to improve brain health assessment. With its headquarters in Melbourne, Australia, the company has expanded its global presence, serving various sectors including pharmaceuticals, biotechnology, and academic research. CogState has developed cutting-edge technologies and software platforms to deliver accurate and efficient cognitive assessments, benefiting patients, researchers, and professionals worldwide. Known for its advanced cognitive testing methods and commitment to enhancing brain health, CogState Ltd has established itself as a trusted industry leader.
CogState Ltd has achieved several significant milestones in its history. One key achievement is the development and commercialization of its pioneering cognitive testing technology, known as the CogState Computerized Cognitive Assessment Tool (CCAT). This innovative tool is widely utilized in clinical trials and research studies worldwide, enabling precise and objective measurement of cognitive function. Additionally, CogState Ltd has successfully established strategic partnerships with leading pharmaceutical companies, academic institutions, and healthcare providers, facilitating the widespread adoption of its solutions. The company continues to thrive through ongoing research and development, further cementing its position as a global leader in cognitive assessment technology.
CogState Ltd is primarily present in Australia, the United States, and Europe.
CogState Ltd represents a set of core values and a corporate philosophy that drive its operations. The company is committed to innovation, delivering cutting-edge solutions in the fields of cognitive assessment and clinical trials. CogState prioritizes integrity, ensuring transparent and ethical practices in all aspects of its business. With a focus on collaboration, CogState fosters strong partnerships to drive mutual success. The company values dedication to excellence, constantly striving for improvement and delivering high-quality products and services. CogState fosters a customer-centric approach, prioritizing customer satisfaction and delivering tailored solutions. Overall, CogState Ltd embodies a commitment to innovation, integrity, collaboration, excellence, and customer-centricity in its corporate philosophy.
Analysts currently set an average price target of 2.21 USD for the CogState stock (median: 2.21 USD), implying +0.8 % versus the latest price. The consensus is based on 6 analyst ratings.
7 analysts currently rate the CogState stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect CogState to generate revenue of 128.65 M USD and earnings per share of 0.09 USD.
Converted at the current exchange rate, the CogState share trades at 1.91 EUR (2.22 USD).
The CogState share (CGS.AX) is listed on 2 stock exchanges, including: ASX (CGS.AX).
CogState Ltd is an innovative company specializing in the development and marketing of cognitive testing solutions. The company offers a wide range of products and services that can be used in the fields of pharmaceutical research, clinical diagnostics, and sports performance optimization. The three main business divisions of CogState Ltd include research and development of cognitive tests, clinical diagnostics and monitoring of patients with neurodegenerative disorders, and solutions for improving sports performance. The company's products are rooted in today's technology, as they are exclusively offered online. They allow for remote diagnosis and supervision of patients, saving time for therapists and improving diagnostic accuracy. The company's proprietary software platform enables researchers to effectively manage their studies and present study results in a concise format. CogState Ltd has a strategy in place to continue offering unique and expanding product offerings, allowing the company to remain a strong competitor in the industry.
The expected revenue of CogState is 128.65 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of CogState is 16.22 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of CogState is currently 23.76. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the CogState stock.
The price-to-sales ratio (P/S) of CogState is currently 3.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the CogState stock.
The Eulerpool Quality Score for CogState is 6/10.
The ISIN of CogState is AU000000CGS8. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of CogState is CGS.AX. The ticker symbol is used to trade CogState shares on the stock exchange.
Over the past 12 months, CogState paid a dividend of 0.03 USD . This corresponds to a dividend yield of about 1.29 %. For the coming 12 months, CogState is expected to pay a dividend of 0.03 USD.
The current dividend yield of CogState is 1.29 %.
CogState paid dividends every year for the past 1 years.
For the upcoming 12 months, dividends amounting to 0.03 USD are expected. This corresponds to a dividend yield of 1.29 %.
CogState is assigned to the 'Health' sector.
To receive the latest dividend of CogState from amounting to 0.03 USD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
The dividends of CogState are distributed in USD.
CogState stock
CogState Peer Group
CogState Ticker
CogState FIGI
All fundamentals and in-depth analysis of CogState
Our stock analysis for CogState stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CogState. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.